reSee.it - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary
This is a systemic issue that needs addressing. I've expressed concern about a future where the FDA is remembered for allowing society to gain weight annually, only to respond with an expensive drug costing $20,000 a year. That would leave a troubling legacy. I hope we can find a better solution.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 76% of Americans are personally bankrupt due to health issues. People know what to do to be healthier, but they don't do it because they think another year won't matter. This is bankrupting families across America. It is important and should be everyone's passion.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its European manufacturer. Once Medicare approves it, Medicaid follows. There's a push to prescribe Ozempic to kids as young as six for obesity, a largely preventable condition. With 74% of Americans obese, covering everyone's Ozempic would cost $3 trillion annually. Ozempic has made Novo Nordisk Europe's largest company, yet Denmark recommends diet and exercise instead. The company's value relies heavily on projected Ozempic sales in the US. For half the cost, we could provide organic food and gym memberships for every obese American. Why are politicians siding with a Danish company over American farmers and kids? Because Novo Nordisk heavily funds medical research, influencing media, politicians, and medical schools.

Video Saved From X

reSee.it Video Transcript AI Summary
A key principle in this discussion is that prevention is more effective than treatment. The U.S. faces significant challenges with obesity and diabetes, with over 35 million Americans having type 2 diabetes, and about 90% of those individuals being obese. Diabetes not only poses serious health risks but also contributes to conditions like heart disease and kidney failure. The financial burden is immense, with diabetes-related costs reaching nearly $413 billion, accounting for about 10% of total healthcare spending. The link between obesity and diabetes is clear, and it's crucial to address these intertwined epidemics.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. This drug, aimed at treating obesity—a largely preventable condition—could cost the U.S. $3 trillion annually if prescribed widely, as 74% of Americans are obese. While Novo Nordisk thrives, the Danish government promotes diet and exercise instead. For half the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk extends to medical research funding, leading to complicity from media, politicians, and medical schools.

Video Saved From X

reSee.it Video Transcript AI Summary
In 1960, the speaker's uncle, then president, was distressed about physical fitness. Obesity was at 13%; today it's at 45%. 75% of Americans are overweight. Chronic disease affected 6% of Americans when he was in office, but by 2006, it was at 54%. The speaker ran for president to end the chronic disease epidemic and restore Americans to good health. A country is as strong as its citizens, and mental and physical health go hand in hand.

Video Saved From X

reSee.it Video Transcript AI Summary
Billions are spent on ineffective weight loss products annually. Livestock farmers know the secret to weight loss: providing essential minerals to animals. When minerals are removed, animals overeat due to deficiencies, leading to weight gain. This triggers a switch in the body to store fat as a survival mechanism. Obesity is linked to mineral deficiencies, not excess calories. By supplementing with essential minerals, cravings decrease, leading to natural weight loss. Exercise exacerbates mineral loss, making weight loss challenging. Proper mineral supplementation and exercise can lead to rapid weight loss without effort. It's time to address the root cause of obesity and prioritize mineral intake for weight management.

Video Saved From X

reSee.it Video Transcript AI Summary
America has an addiction crisis related to food, which is profitable for big food companies whose objective is to create cheap, addictive food. Almost every chronic condition shortening American lives is tied to food. Ultra-processed food makes up 70% of our diet and is weaponized with sugar, seed oils, and processed grains. The speaker claims the food market is rigged, and while working for the food industry, they helped pay off regulators, the media, lawmakers, and researchers to promote ultra-processed food as healthy. Coca-Cola allegedly pays organizations like the American Academy of Pediatrics. The food industry is purportedly taking away humans' innate sense of what's good for them, hiring scientists from tobacco companies to shift them over to food science. Ultra-processed food is a science experiment that hijacks our evolutionary biology, making food addictive and normalized.

Video Saved From X

reSee.it Video Transcript AI Summary
Ozempic breaks people's bones. Pharmaceutical companies selling weight loss pills have side effects that include breaking people's bones. Instead of cleaning up their diet, eating organic, working out, getting rid of Wi Fi, and spending time in nature, people are going to pharmaceutical companies expecting results. When your bones break in half, it doesn't matter if you lose weight. Taking care of yourself and being healthy takes work. If you're concerned about weight loss, you should be concerned about what's in your house, what you're eating, the chemicals you're spraying all over your body, and the lotions you're putting all over your head. If you can't lose weight, it's probably your diet, and an all-organic diet can heal everything. Pharmaceutical companies poison people to gain weight, then sell them something to make them lose weight, which causes their bones to break, creating patients for life.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1,500 monthly, with most having received money from Novo Nordisk, its manufacturer. Approval for Medicare would extend to Medicaid, with potential recommendations for Americans as young as six for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the total cost of Ozempic prescriptions could reach $3 trillion annually. Ozempic has made Novo Nordisk the biggest company in Europe, yet the Danish government recommends diet and exercise instead. The company's value relies on projected Ozempic sales in America. For half the cost of Ozempic, every American could receive regeneratively raised organic food and obese Americans could receive gym memberships. The speaker questions why Congress is supporting Novo Nordisk over American farmers and children, suggesting Novo Nordisk's funding of medical research influences media, politicians, and medical schools.

Video Saved From X

reSee.it Video Transcript AI Summary
Medicine is important for specific treatments, but primary care should emphasize lifestyle changes before prescribing medication. It's easier to prescribe drugs like omeprazole than to advise weight loss and dietary changes, but these medications can cause problems like osteoporosis or C. Diff. Overweight patients often need higher doses of medication, but weight loss should be the first step. Doctors may over-prescribe medication to allow patients to continue unhealthy habits, like eating steak. Instead, people should balance indulgences with healthier choices. Doctors may favor drugs like Ozempic because they offer a quick solution when lifestyle changes seem improbable. Insurance may cover weight loss medication but offer limited support for nutritionists. There should be incentives in the workplace to encourage exercise.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. Once approved for Medicare, the drug will likely extend to Medicaid, with recommendations for use in children as young as 6 for obesity, a largely preventable condition. With 74% of Americans classified as obese, the potential annual cost for Ozempic prescriptions could reach $3 trillion. While Novo Nordisk thrives on these projections, the Danish government advocates for dietary changes and exercise instead. For the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk in medical research funding raises concerns about Congress prioritizing corporate interests over American health and agriculture.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. Once approved for Medicare, it goes to Medicaid, and there's a push to recommend Ozempic for Americans as young as 6 for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the cost of Ozempic prescriptions for all of them would be $3 trillion a year. Novo Nordisk's value is based on projected Ozempic sales to Americans, yet the Danish government recommends diet and exercise instead. For half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. Congress is allegedly doing the bidding of Novo Nordisk instead of supporting American farmers and children because Novo Nordisk heavily funds medical research, the media, politicians, and medical schools.

Video Saved From X

reSee.it Video Transcript AI Summary
Over a hundred members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its manufacturer. Once Medicare approves, Medicaid follows. There's a push to prescribe Ozempic for obesity in Americans as young as six, a condition largely preventable. With 74% of Americans obese, covering Ozempic prescriptions would cost $3 trillion annually. Novo Nordisk's value relies heavily on projected Ozempic sales in the US, yet Denmark, their home country, favors diet and exercise over the drug. For half the cost of Ozempic, we could provide regeneratively raised organic food to every American, three times a day, and gym memberships for every obese American. Why is Congress prioritizing this company over American well-being? I've dedicated my life to solving the childhood chronic disease crisis, and I see an opportunity for bipartisan change to improve American health, our economy, and our nation's spirit.

Video Saved From X

reSee.it Video Transcript AI Summary
Ozempic has rapidly become a cultural phenomenon, with one in eight US adults having tried GLP-1 drugs. The company producing Ozempic is now valued higher than Coca-Cola and McDonald's combined. Online discussions mention side effects like Ozempic face, hair loss, and severe stomach problems, alongside reports suggesting potential benefits for fertility, Alzheimer's, and even shopping addiction. The speaker questions the complete truth about GLP-1 drugs and weight loss, and has spent months researching and attempting to obtain GLP-1 medication.

Video Saved From X

reSee.it Video Transcript AI Summary
Big food, big pharma, big chemicals get super wealthy. Right? What is the product of health care? It's a healthy body. If we take The US population and compare it to the world, we're at the very bottom when it comes to health, yet we spend the most for health care. Over $4,100,000,000,000 every single year.

Video Saved From X

reSee.it Video Transcript AI Summary
The average 65-year-old in the US takes about seven drugs. 95% of people on the USDA nutrition guidelines had conflicts of interest with food companies, influencing school lunches, where the USDA serves 3 billion meals yearly. Kraft Heinz is brokering deals to put Lunchables in schools, a top growth area. Novo Nordisk, the Ozempic manufacturer, is now Europe's most valuable company, with almost all revenue from the US due to a broken system. 30% of Americans with insurance coverage stop using Ozempic within three months, despite it being touted as a lifetime drug. Lawsuits are emerging regarding gastrointestinal issues and stomach paralysis, which may persist after discontinuing the drug. The EU is probing suicidal ideation linked to Ozempic. The American Academy of Pediatrics recommends Ozempic as a first-line defense for teens based on a 68-week study. Pharma is the largest TV news ad spender, and Novo Nordisk is a major funder of obesity research, medical groups, and civil rights groups, including paying the NAACP, who claims that not supporting Ozempic is racist. Analyst reports assume increased obesity rates, and loans for obesity treatment centers project growth in obesity. Weight Watchers, now an Ozempic prescriber, shifted from personal accountability due to Ozempic's superior business model.

Video Saved From X

reSee.it Video Transcript AI Summary
Childhood obesity in America has tripled since the 1970s, with one in five children now obese, and over 40% of adults facing obesity. This crisis stems from the food industry’s focus on profit, promoting ultra-processed foods high in sugar, salt, and fat. These foods, which comprise 73% of the food supply, are designed to be addictive, contributing to health issues like type 2 diabetes. The industry spends $14 billion annually on advertising, with $2 billion targeting children to create lifelong consumers. Children see about 4,000 food ads each year, with companies like Coca-Cola investing heavily in marketing while obscuring the health risks associated with their products, such as high sugar content and increased diabetes risk. This issue has been acknowledged by experts for years.

Video Saved From X

reSee.it Video Transcript AI Summary
Ozempic, a diabetes drug that aids weight loss, is gaining popularity despite concerns. Cali Means highlights three major issues: first, obesity is a symptom of deeper metabolic dysfunction, not a deficiency treatable by medication. Second, the drug has significant side effects, including gastrointestinal issues and potential mental health risks, with many users discontinuing it within months. Third, systemic corruption in healthcare, where pharmaceutical companies influence medical guidelines and funding, exacerbates the problem. Instead of addressing root causes like diet and lifestyle, the focus remains on lifelong drug dependency. Means advocates for a shift towards preventive measures, emphasizing better nutrition and exercise as essential for improving public health. He believes that reforming healthcare practices and policies can reverse the current metabolic health crisis.

Video Saved From X

reSee.it Video Transcript AI Summary
The U.S. faces a severe chronic disease crisis, costing $4.3 trillion annually, which is five times the military budget. Medical expenses for chronic diseases have skyrocketed from zero during previous administrations to 95% of healthcare spending today. This situation is exacerbated by processed foods, chemicals, and a profit-driven healthcare system that benefits from keeping people sick. Pharmaceutical companies profit from lifelong patients, with drugs like Ozempic costing $1,500 weekly. A proposed bill could lead to $3 trillion in costs for treating obesity. Instead, for a fraction of that amount, providing every American with three organic meals daily could eliminate diabetes, a condition treatable with proper nutrition and exercise.

20VC

Sami Inkinen: "Why the Two Weeks Following Our IPO Were the Worst of my Life" | E1120
Guests: Sami Inkinen
reSee.it Podcast Summary
Growing up on a farm in Finland near the Russian border, I had humble beginnings, doing manual labor like picking potatoes and feeding chickens. My parents were factory workers, so I had no professional role models. Getting a Commodore 64 before age 10 fueled my dream of creating something valuable for others. My move to America to build a company still feels unreal to my mom. After our IPO, instead of joy, I felt panic and disappointment. This was one of the lowest moments in my life. To address this, I attended a 10-day silent meditation retreat in Taiwan and have meditated ever since. Authenticity and vulnerability are key, striving to be the same person in all roles. During a Pacific row, I realized I had never truly observed my thoughts and emotions. This was a turning point, understanding that the mind needs reflection to stay on course. My mission is to help potentially billions restore their metabolic health by addressing obesity and diabetes, aiming to reverse diabetes globally. I prioritize sleep, averaging seven to eight hours a night, and treat myself like an Olympic athlete, focusing on the foundations of health and disciplined routines. Our goal is to make people healthy, not just sell drugs to treat symptoms of obesity and type 2 diabetes.

My First Million

The Dark Story Behind Ozempic’s $500B Business Empire
reSee.it Podcast Summary
The discussion centers around the issue of obesity and the use of OIC (Obesity Intervention Drugs) in America, which the hosts argue is symptomatic of a larger problem in the healthcare system. Telly describes OIC as "liquefied anorexia," suggesting that it merely masks the root causes of obesity rather than addressing them. He criticizes the medical education system for neglecting nutrition training, citing an anecdote about a Stanford surgeon dismissing dietary interventions. Kelly highlights the alarming statistics of obesity in America, noting that 50% of teens are overweight or obese, compared to just 3% in Japan. He argues that the healthcare industry profits from managing chronic diseases rather than preventing them, with a focus on drugging patients instead of addressing lifestyle factors. The conversation touches on the influence of pharmaceutical companies on medical education and policy, revealing that many medical schools are funded by these companies, which affects the integrity of healthcare recommendations. The hosts discuss the economic implications of the obesity crisis, predicting that healthcare costs could consume 40% of GDP in the next 20 years. They emphasize the need for systemic change, advocating for a shift towards healthier food systems and incentivizing better lifestyle choices rather than relying on drugs like Ozempic. They also explore the historical context of the pharmaceutical industry, linking it to the rise of chronic conditions and the segmentation of medical specialties that prioritize profit over holistic health. The conversation concludes with a call to action for entrepreneurs and investors to focus on sustainable health solutions, emphasizing that the current trajectory is unsustainable and detrimental to American society. The hosts express a desire for a healthier future, advocating for a reevaluation of dietary practices and healthcare policies.

Tucker Carlson

Dr. Mark Hyman: Everything You're Eating Is Toxic, and Big Pharma Likes It That Way
Guests: Mark Hyman
reSee.it Podcast Summary
Tucker Carlson and Dr. Mark Hyman discuss the current health crisis in America, emphasizing the rising costs of healthcare, which now amount to nearly $5 trillion, and the prevalence of preventable chronic diseases. Hyman highlights that 80% of healthcare costs stem from preventable conditions, primarily driven by poor dietary choices and a flawed food system. He argues that the food industry, supported by government policies favoring commodity crops like corn and soy, has created an "illness industrial complex" that profits from disease rather than health. Hyman notes that chronic diseases, such as diabetes and heart disease, are on the rise, with obesity rates skyrocketing from 15% to over 40% in many states. He points out that the highest diabetes mortality rates are found in red states, indicating that this issue transcends political affiliations. Hyman believes that the conversation around health has shifted, with more people recognizing the root causes of chronic illness, particularly the role of ultra-processed foods, which make up a significant portion of the American diet. The discussion touches on the impact of marketing and food addiction, particularly among children, with the food industry spending billions on advertising unhealthy products. Hyman cites studies showing that ultra-processed foods lead to increased caloric intake and weight gain, contributing to the obesity epidemic. He argues that the current healthcare system is failing, as it focuses on treating symptoms rather than addressing the underlying causes of disease. Hyman advocates for a comprehensive approach to health that includes dietary changes, education, and policy reform. He suggests that the government could play a crucial role in transforming the food system by supporting healthier agricultural practices and improving nutrition education in medical schools. He emphasizes the need for transparency in food labeling and the importance of informed consent regarding dietary choices. The conversation also addresses the controversial topic of vaccines, with Hyman asserting that while vaccines have historically been beneficial, there should be ongoing research into their long-term safety and efficacy. He criticizes the polarized nature of the vaccine debate and calls for a more nuanced discussion based on scientific evidence. Hyman expresses optimism about the potential for change, particularly with the appointment of figures like Bobby Kennedy as HHS Secretary, who he believes could address the chronic disease epidemic and reform the healthcare system. He concludes by reiterating the importance of focusing on the root causes of health issues, advocating for a shift in how society approaches food and health.

The Megyn Kelly Show

Fighting the Establishment in DC, and Why Woke Lost - Piers Morgan, Eric Trump, and Calley Means
Guests: Piers Morgan, Eric Trump, Calley Means
reSee.it Podcast Summary
Megyn Kelly hosts a wide‑ranging discussion with Piers Morgan, Eric Trump, and Calley Means that blends media critique, political strategy, and public‑health reform with personal anecdotes from the Trump orbit. The episode pivots around a centralized theme: the perceived rise of woke culture and its impact on broadcasting, journalism, and policymaking, including a highlight on Condé Nast and Teen Vogue as symbols of what the guests see as a woke establishment. Megyn frames the conversation with pride in a no‑nonsense, anti‑establishment stance and tees up a rundown of guests who embody different facets of the movement: Piers Morgan’s critique of woke culture and his new book, Woke Is Dead; Eric Trump’s reflections on presidential politics, media bias, and his family’s legal and political battles; and Calley Means’s health‑policy project, Maha, which advocates for systemic healthcare reform and healthier food policies. The dialogue weaves through contemporary hot topics—media double standards, the weaponization of government, and the push to “make America healthy again.” The interview with Calley Means spotlights a policy‑oriented critique of America’s health landscape: rampant obesity, the influence of ultra‑processed foods, and the role of government subsidies. Means describes a reform agenda that seeks to realign incentives toward wellness, reduce dependence on high‑priced drugs like Ozempic, and empower families with practical nutrition and access to better health outcomes. The guests also reflect on immigration, the labor market, and the need to prioritize American workers, with Megyn pressing for deportations of those here illegally unless lawful status is established, while also signaling a broader critique of the political class and the media ecosystem that amplifies partisan narratives. The episode closes with a candid exchange about 2028 political possibilities, the resilience of the MAGA movement, and Eric Trump’s personal assessment of leadership, media, and the path forward for a Republican administration. The conversation is anchored by personal anecdotes—from backstage dynamics to family stories, including exchanges about Barron Trump and the Trump Library—providing a candid portrait of a family and a political movement navigating today’s polarized climate.

Mind Pump Show

Mind Pump Challenges Big Pharma: A Look at The Future of Health in America
reSee.it Podcast Summary
The pharmaceutical industry benefits from a population that is overweight and unhealthy, as they represent a significant consumer base. Dr. Fatima Stanford, a member of the Biden USDA's dietary guidelines advisory committee, claims that genetics is the primary cause of obesity, with a 50 to 80 percent risk of obesity for children of obese parents. She also describes obesity as a brain disease, suggesting that the brain regulates eating and storage. However, the hosts argue that lifestyle factors play a crucial role in obesity and express concern over the narrative that genetics absolves personal responsibility. They highlight the pharmaceutical industry's profit motives, noting that a larger market of obese individuals leads to increased drug sales. The discussion points to the alarming trend of labeling obesity as a disease, which could open the door for more medications and shift focus away from lifestyle changes. The hosts emphasize the importance of empowerment and personal agency in addressing obesity, warning against the potential consequences of accepting a narrative that diminishes individual responsibility.
View Full Interactive Feed